EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

PINK1 dysfunction in hepatocellular carcinoma fosters immune evasion and disease progression by promoting neutrophil infiltration

Zhiyun Gu, Tongwang Yang, Yuanli Ni, Yuanze Zhou, Cheng Qian, Na Zhuang

Journal for ImmunoTherapy of Cancer · 2025

DOI: 10.1136/jitc-2025-013079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, 2025. Verfasst von Zhiyun Gu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqin…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Protein Kinases, Neutrophil Infiltration. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Chongqing Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite breakthroughs in immune checkpoint blockade (ICB) for advanced hepatocellular carcinoma (HCC), tumor immune evasion remains a major limitation to immunotherapy efficacy. PTEN-induced putative kinase 1 (PINK1) has highlighted roles in immune system regulation and tumor progression, but its specific role in HCC and impact on ICB response remains unclear. This study aimed to elucidate how PINK1 dysfunction enables HCC adaptation to ICB-induced immune attacks and identify potential therapeutic targets.

Methods

Online patient dataset analyses were performed to evaluate the impact of reduced PINK1 expression on clinical prognosis in HCC. An orthotopic HCC tumor cell mouse model was established. Single-cell RNA sequencing and flow cytometry were employed to explore the immune characteristics and remodeling of the tumor microenvironment in PINK1-deficient HCC. Neutrophils and T cells were isolated, stimulated, and/or cultured for ex vivo functional assays. Gene Expression Omnibus database analyses were performed to identify key genes involved in HCC resistance to ICB.

Results

We identified PINK1 as a key mediator of ICB resistance in HCC. We found that PINK1 expression was significantly reduced in ICB-resistant HCC and a reduced PINK1 signature was associated with poorer clinical outcomes in patients with HCC. Importantly, PINK1 deficiency serves as a predictive biomarker for diminished responsiveness to immunotherapy. Function experiments have revealed that PINK1 regulates HCC progression and infiltration and activation of neutrophils and T cells. Mechanistically, the tumor cell-intrinsic downregulation of PINK1 activated the production of chemokines involved in neutrophil recruitment, and tumor-infiltrating neutrophils inhibited T cell activity. Additionally, a neutrophil-depleting antibody resensitized tumors to antiprogrammed death-ligand 1 therapy in orthotopic HCC models, further demonstrating that neutrophils are the primary population responsible for the adaptation of cancer cells with reduced PINK1 to ICB-induced immune attacks.

Conclusions

Our study uncovered PINK1 as both a predictor of the ICB response and a key mediator of immune evasion by promoting neutrophil infiltration. These results highlight that the therapeutic targeting of neutrophils may represent a viable strategy to overcome ICB resistance in HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsProtein KinasesNeutrophil InfiltrationTumor EscapeImmune EvasionHumansAnimalsMiceDisease ProgressionTumor MicroenvironmentMaleFemaleNeutrophilsPTEN-Induced Putative Kinase

Stichwörter der Autor:innen

combination therapyhepatocellular carcinomaimmune checkpoint inhibitorimmune modulatoryimmunotherapy

Substanzen

Protein KinasesPTEN-Induced Putative Kinase

Autor:innen und Institutionen

  • Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China.
  • Department of Hematology, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China zhuangna0618@163.com zhou_yuanze@tmmu.edu.cn cqian8634@gmail.com.
  • Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China zhuangna0618@163.com zhou_yuanze@tmmu.edu.cn cqian8634@gmail.…

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Chongqing Municipality

Zitieren

APA

Gu, Z., Yang, T., Ni, Y., Zhou, Y., Qian, C., & Zhuang, N. (2025). PINK1 dysfunction in hepatocellular carcinoma fosters immune evasion and disease progression by promoting neutrophil infiltration. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2025-013079

Vancouver

Gu Z, Yang T, Ni Y, Zhou Y, Qian C, Zhuang N. PINK1 dysfunction in hepatocellular carcinoma fosters immune evasion and disease progression by promoting neutrophil infiltration. Journal for ImmunoTherapy of Cancer. 2025. doi:10.1136/jitc-2025-013079

BibTeX
@article{Gu2025,
  author = {Gu, Zhiyun and Yang, Tongwang and Ni, Yuanli and Zhou, Yuanze and Qian, Cheng and Zhuang, Na},
  title = {PINK1 dysfunction in hepatocellular carcinoma fosters immune evasion and disease progression by promoting neutrophil infiltration},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2025},
  doi = {10.1136/jitc-2025-013079}
}
Kostenlos starten →